Article
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
Human molecular genetics - 15 Oct 2012
Cruchaga Carlos, Kauwe John S K, Nowotny Petra, Bales Kelly, Pickering Eve H, Mayo Kevin, Bertelsen Sarah, Hinrichs Anthony, Fagan Anne M, Holtzman David M, Morris John C, Goate Alison M
Abstract excerpt
The apolipoprotein E (APOE) genotype is the major genetic risk factor for Alzheimer's disease (AD). We have access to cerebrospinal fluid (CSF) and plasma APOE protein levels from 641 individuals and genome-wide genotyped data from 570 of these samples. The aim of this study was to test whether CSF or plasma APOE levels could be a useful endophenotype for AD and to identify genetic variants associated with APOE...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
